Skip to content
15 715 715 7

Drawing based on the label description. No photo yet.

“80 mg. white to tan tablets debossed on one side with "15" over "7"”

15 7 pill

Pill with imprint 15 7 is white, round, 12 mm and has been identified as Nilotinib 80 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Cycle Pharmaceuticals Ltd.

Nilotinib 80 mg

Imprint
15 7
Strength
80 mg
Used for
Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
Color
White
Shape
Round
Size
12 mm
Score
No score line
Form
Tablet, orally disintegrating
Manufacturer
Cycle Pharmaceuticals Ltd
Drug class
Cancer medicine (kinase inhibitor)
NDC
70709-192, 70709-192-12

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Nilotinib pills and guides

What is Nilotinib used for?

Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Adult Patients With Newly Diagnosed Ph+ CML-CP

Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP

Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 15 7 and the other side has no imprint.
  • It is white, round, 12 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Cavhanza.

Ingredients

Active: Nilotinib

Inactive: Hypromellose Acetate Succinate, Unspecified, Butylated Hydroxytoluene, Microcrystalline Cellulose, Mannitol 1-Acetate, Crospovidone, Magnesium Stearate, Silicon Dioxide, Starch, Corn

Other pills with imprint 15 7

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Nilotinib pills